Stock-Based Compensation

6 Months Ended

Jun. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income (Loss), based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and six months ended June 30, 2014 and 2013, was as follows:



	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2014		2013		2014		2013
Cost of goods sold	$	197	$	227	$	404	$	377
Operating expenses:
Research and development	185		191		335		396
Clinical and regulatory affairs	365		35		262		438
Marketing and sales	645		1,087		1,194		1,665
General and administrative	748		557		1,558		1,451
Total operating expenses	$	1,943	$	1,870	$	3,349	$	3,950
Total	$	2,140	$	2,097	$	3,753	$	4,327

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References+ Details